{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:51:48Z","timestamp":1787237508498,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K25AG083064"],"award-info":[{"award-number":["K25AG083064"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R21AG070404"],"award-info":[{"award-number":["R21AG070404"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG073104"],"award-info":[{"award-number":["P30AG073104"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.inpsyc.2025.100105","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T23:46:47Z","timestamp":1750808807000},"page":"100105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Brain morphological characteristics predicting clinical response to selective serotonin reuptake inhibitors or cholinesterase inhibitors: A study of electronic medical records in patients with cognitive disorders"],"prefix":"10.1016","volume":"37","author":[{"given":"Kengo","family":"Onda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill S.","family":"Chotiyanonta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6420-0218","authenticated-orcid":false,"given":"Hannah P.","family":"Cowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6521-0784","authenticated-orcid":false,"given":"Yuto","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milap A.","family":"Nowrangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantine G.","family":"Lyketsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter P.","family":"Zandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1200-8611","authenticated-orcid":false,"given":"Kenichi","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.inpsyc.2025.100105_bib1","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3233\/JAD-230106","article-title":"Nationwide Database analysis of risk factors associated with decreased activities of daily living in patients with Alzheimer's disease","volume":"94","author":"Akada","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.inpsyc.2025.100105_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2023.105121","article-title":"Alzheimer`s disease mortality in the United States: cross-sectional analysis of county-level socio-environmental factors","volume":"115","author":"Salerno","year":"2023","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.inpsyc.2025.100105_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.29392","article-title":"Evaluation of the cost-effectiveness of drug treatment for Alzheimer disease in a simulation model that includes caregiver and societal factors","volume":"4","author":"Ito","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.inpsyc.2025.100105_bib4","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1590\/1980-57642016dn11-040005","article-title":"Mixed dementia: a review of the evidence","volume":"11","author":"Custodio","year":"2017","journal-title":"Dement Neuropsychol"},{"key":"10.1016\/j.inpsyc.2025.100105_bib5","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1001\/jama.292.23.2901","article-title":"Mixed dementia: emerging concepts and therapeutic implications","volume":"292","author":"Langa","year":"2004","journal-title":"JAMA J Am Med Assoc"},{"key":"10.1016\/j.inpsyc.2025.100105_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12916-014-0206-2","article-title":"The overlap between vascular disease and Alzheimer's disease--lessons from pathology","volume":"12","author":"Attems","year":"2014","journal-title":"BMC Med"},{"key":"10.1016\/j.inpsyc.2025.100105_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12929-023-00976-6","article-title":"Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update","volume":"30","author":"Huang","year":"2023","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.inpsyc.2025.100105_bib8","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-132690","article-title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"41","author":"Tan","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.inpsyc.2025.100105_bib9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2377-12-134","article-title":"Functional response to cholinesterase inhibitor therapy in a naturalistic Alzheimer's disease cohort","volume":"12","author":"Wattmo","year":"2012","journal-title":"BMC Neurol"},{"key":"10.1016\/j.inpsyc.2025.100105_bib10","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40120-019-00148-5","article-title":"Diagnosing and treating depression in patients with Alzheimer's disease","volume":"8","author":"Burke","year":"2019","journal-title":"Neurol Ther"},{"key":"10.1016\/j.inpsyc.2025.100105_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12888-019-2025-7","article-title":"Clinical guidelines for the management of depression with specific comorbid psychiatric conditions French recommendations from experts (the French Association for Biological Psychiatry and Neuropsychopharmacology and the fondation FondaMental)","volume":"19","author":"Bennabi","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.inpsyc.2025.100105_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","article-title":"Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice","volume":"163","author":"Trivedi","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.inpsyc.2025.100105_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00002093-199501002-00007","article-title":"Clinical heterogeneity: responders to cholinergic therapy","volume":"9","author":"Eagger","year":"1995","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.inpsyc.2025.100105_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005593","article-title":"Cholinesterase inhibitors for Alzheimer's disease","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst Rev (Online)"},{"key":"10.1016\/j.inpsyc.2025.100105_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144337","article-title":"Adverse effects of cholinesterase inhibitors in dementia, according to the pharmacovigilance databases of the United-States and Canada","volume":"10","author":"Ali","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.inpsyc.2025.100105_bib16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2217\/nmt.14.35","article-title":"Role of citalopram in the treatment of agitation in Alzheimer's disease","volume":"4","author":"Porsteinsson","year":"2014","journal-title":"Neurodegener Dis Manag"},{"key":"10.1016\/j.inpsyc.2025.100105_bib17","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1592\/phco.29.7.822","article-title":"Pharmacogenetics of selective serotonin reuptake inhibitors and associated adverse drug reactions","volume":"29","author":"Thomas","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.inpsyc.2025.100105_bib18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1752-8062.2008.00003.x","article-title":"Right drug-right patient-right time: personalized medicine coalition","volume":"1","author":"Abrahams","year":"2008","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.inpsyc.2025.100105_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186595","article-title":"MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesis","volume":"12","author":"Persson","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.inpsyc.2025.100105_bib20","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.dadm.2015.11.008","article-title":"Prediction of Alzheimer's disease pathophysiology based on cortical thickness patterns","volume":"2","author":"Hwang","year":"2016","journal-title":"Alzheimers Dement (Amst"},{"key":"10.1016\/j.inpsyc.2025.100105_bib21","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1212\/WNL.0000000000001003","article-title":"Anatomical heterogeneity of Alzheimer disease: based on cortical thickness on MRIs","volume":"83","author":"Noh","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.inpsyc.2025.100105_bib22","article-title":"Robust Identification of Alzheimer's Disease subtypes based on cortical atrophy patterns","volume":"7","author":"Park","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.inpsyc.2025.100105_bib23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.neurobiolaging.2018.01.009","article-title":"Heterogeneous patterns of brain atrophy in Alzheimer's disease","volume":"65","author":"Poulakis","year":"2018","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.inpsyc.2025.100105_bib24","first-page":"735","article-title":"Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers","volume":"140","author":"Dong","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.inpsyc.2025.100105_bib25","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9507193","article-title":"Cloud-based brain magnetic resonance image segmentation and parcellation system for individualized prediction of cognitive worsening","volume":"2019","author":"Sakamoto","year":"2019","journal-title":"J Health Eng"},{"key":"10.1016\/j.inpsyc.2025.100105_bib26","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1093\/brain\/awy264","article-title":"Atrophy subtypes in prodromal Alzheimer's disease are associated with cognitive decline","volume":"141","author":"Ten Kate","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.inpsyc.2025.100105_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mam.2015.05.005","article-title":"Neuropsychiatric symptoms in Alzheimer's disease: what might be associated brain circuits?","volume":"43-44","author":"Rosenberg","year":"2015","journal-title":"Mol Asp Med"},{"key":"10.1016\/j.inpsyc.2025.100105_bib28","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1017\/S1041610220000113","article-title":"The association of neuropsychiatric symptoms with regional brain volumes from patients in a tertiary multi-disciplinary memory clinic","volume":"33","author":"Nowrangi","year":"2021","journal-title":"Int Psychogeriatr \/ IPA"},{"key":"10.1016\/j.inpsyc.2025.100105_bib29","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1001\/archneur.62.11.1718","article-title":"Neuroanatomical predictors of response to donepezil therapy in patients with dementia","volume":"62","author":"Csernansky","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.inpsyc.2025.100105_bib30","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1093\/brain\/aws173","article-title":"Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies","volume":"135","author":"Graff-Radford","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.inpsyc.2025.100105_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1155\/2012\/538542","article-title":"GOOD or BAD responder? Behavioural and neuroanatomical markers of clinical response to donepezil in dementia","volume":"25","author":"Bottini","year":"2012","journal-title":"Behav Neurol"},{"key":"10.1016\/j.inpsyc.2025.100105_bib32","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/MNM.0b013e3282f5e5f4","article-title":"Prediction of response to donepezil in Alzheimer's disease: combined MRI analysis of the substantia innominata and SPECT measurement of cerebral perfusion","volume":"29","author":"Kanetaka","year":"2008","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.inpsyc.2025.100105_bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0304-3940(01)02507-1","article-title":"Atrophy of the substantia innominata on magnetic resonance imaging and response to donepezil treatment in Alzheimer's disease","volume":"319","author":"Hanyu","year":"2002","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.inpsyc.2025.100105_bib34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.36518\/2689-0216.1094","article-title":"Improving the Quality and Design of Retrospective Clinical Outcome Studies that Utilize Electronic Health Records","volume":"1","author":"Dziadkowiec","year":"2020","journal-title":"HCA Health J Med"},{"key":"10.1016\/j.inpsyc.2025.100105_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1177026","article-title":"Translating clinical notes into quantitative measures-a real-world observation on the response to cholinesterase inhibitors or selective serotonin reuptake inhibitors prescribed to outpatients with dementia using electronic medical records","volume":"14","author":"Chotiyanonta","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.inpsyc.2025.100105_bib36","article-title":"Bayesian parameter estimation and segmentation in the Multi-Atlas Random Orbit Model","volume":"8","author":"Tang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.inpsyc.2025.100105_bib37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13195-020-00658-7","article-title":"The contribution of vascular risk factors in neurodegenerative disorders: from mild cognitive impairment to Alzheimer's disease","volume":"12","author":"Cheng","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.inpsyc.2025.100105_bib38","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/STROKEAHA.121.032614","article-title":"Trials and treatments for vascular brain health: risk factor modification and cognitive outcomes","volume":"53","author":"Kivipelto","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.inpsyc.2025.100105_bib39","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.neuroimage.2009.01.002","article-title":"Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants","volume":"46","author":"Oishi","year":"2009","journal-title":"NeuroImage"},{"key":"10.1016\/j.inpsyc.2025.100105_bib40","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.neuroimage.2009.04.057","article-title":"Multi-contrast large deformation diffeomorphic metric mapping for diffusion tensor imaging","volume":"47","author":"Ceritoglu","year":"2009","journal-title":"NeuroImage"},{"key":"10.1016\/j.inpsyc.2025.100105_bib41","article-title":"Improved generalized ComBat methods for harmonization of radiomic features","volume":"12","author":"Horng","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.inpsyc.2025.100105_bib42","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41593-022-01186-3","article-title":"Mapping neurotransmitter systems to the structural and functional organization of the human neocortex","volume":"25","author":"Hansen","year":"2022","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.inpsyc.2025.100105_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fncir.2020.00037","article-title":"The nucleus accumbens: a common target in the comorbidity of depression and addiction","volume":"14","author":"Xu","year":"2020","journal-title":"Front Neural Circuits"},{"key":"10.1016\/j.inpsyc.2025.100105_bib44","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2174\/157015906778520773","article-title":"Neurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodents","volume":"4","author":"Shirayama","year":"2006","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.inpsyc.2025.100105_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3233\/JAD-221247","article-title":"Neuropsychiatric symptoms of Alzheimer's disease: an anatomic-genetic framework for treatment development","volume":"95","author":"Nowrangi","year":"2023","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.inpsyc.2025.100105_bib46","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s002130100746","article-title":"Association between depressive behavior and absence of serotonin-dopamine interaction in the nucleus accumbens","volume":"155","author":"Zangen","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.inpsyc.2025.100105_bib47","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/ana.410310608","article-title":"Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease","volume":"31","author":"Sparks","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.inpsyc.2025.100105_bib48","first-page":"120","article-title":"A high-resolution in vivo atlas of the human brain's serotonin system","volume":"37","author":"Beliveau","year":"2017","journal-title":"J Neurosci"},{"key":"10.1016\/j.inpsyc.2025.100105_bib49","unstructured":"Raote I., Bhattacharya A., Panicker M.M. Serotonin 2A (5-HT(2A)) receptor function: ligand-dependent mechanisms and pathways. In: Chattopadhyay A., ed. Serotonin receptors in neurobiology. Boca Raton (FL); 2007."},{"key":"10.1016\/j.inpsyc.2025.100105_bib50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/7854_2017_478","article-title":"Hallucinogens and serotonin 5-HT(2A) receptor-mediated signaling pathways","volume":"36","author":"Lopez-Gimenez","year":"2018","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.inpsyc.2025.100105_bib51","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s12325-018-0805-y","article-title":"Interpretation and impact of real-world clinical data for the practicing clinician","volume":"35","author":"Blonde","year":"2018","journal-title":"Adv Ther"},{"key":"10.1016\/j.inpsyc.2025.100105_bib52","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/picr.picr_62_21","article-title":"Introduction to real-world evidence studies","volume":"12","author":"Chodankar","year":"2021","journal-title":"Perspect Clin Res"},{"key":"10.1016\/j.inpsyc.2025.100105_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2019.116450","article-title":"Harmonization of large MRI datasets for the analysis of brain imaging patterns throughout the lifespan","volume":"208","author":"Pomponio","year":"2020","journal-title":"Neuroimage"},{"key":"10.1016\/j.inpsyc.2025.100105_bib54","article-title":"Proceed with caution when using real world data and real world evidence","volume":"34","author":"Kim","year":"2019","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.inpsyc.2025.100105_bib55","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1136\/ebmental-2019-300134","article-title":"Natural language processing for structuring clinical text data on depression using UK-CRIS","volume":"23","author":"Vaci","year":"2020","journal-title":"Evid Based Ment Health"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610225003436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610225003436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T08:31:08Z","timestamp":1779006668000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610225003436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1041610225003436"],"URL":"https:\/\/doi.org\/10.1016\/j.inpsyc.2025.100105","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brain morphological characteristics predicting clinical response to selective serotonin reuptake inhibitors or cholinesterase inhibitors: A study of electronic medical records in patients with cognitive disorders","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.inpsyc.2025.100105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Psychogeriatric Association.","name":"copyright","label":"Copyright"}],"article-number":"100105"}}